MicroPort NeuroScientific Corporation (HKG:2172)

Market Cap	5.30B -13.5%
Revenue (ttm)	879.66M +3.8%
Net Income	205.32M -27.4%
EPS	0.36 -27.1%
Shares Out	575.57M
PE Ratio	25.84
Forward PE	18.92
Dividend	0.14 (1.52%)
Ex-Dividend Date	Jul 2, 2026

Volume	9,377,000
Open	9.40
Previous Close	8.96
Day's Range	9.03 - 9.83
52-Week Range	8.62 - 19.06
Beta	0.00
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 27, 2026

About MicroPort NeuroScientific

MicroPort NeuroScientific Corporation provides neuro-interventional medical devices. The company provides NUMEN Silk, a electronically detachable coil; Numen Lighting, a coil embolization system; Numen Nest, a detachable coil; NuFairy absorbable coil embolization system; Tubridge, a flow-diverting stent; Tubridge Plus, a flow-diverting stent; WILLIS, a intracranial stent graft system; Comaneci, a embolization assist device; and Rebridge, an intracranial visualized stent for intracranial aneurysm, as well as liquid embolic agent for cerebral art...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2004
• Employees: 547
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2172

Financial Performance

In 2025, MicroPort NeuroScientific's revenue was 790.48 million, an increase of 3.77% compared to the previous year's 761.76 million. Earnings were 184.51 million, a decrease of -27.41%.

Financial numbers in CNY